See All Slides - tctmd.com

Slides

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Truls R?munddal

October 29, 2013

Presentation TCT 2013

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Presenter: John Puskas

October 29, 2013

Presentation TCT 2013

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Presenter: Loes Hoebers

October 29, 2013

Presentation TCT 2013

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Presenter: Larry Wood

October 29, 2013

Presentation TCT 2013

Case 1: Complex Coronary Artery Disease (Mount Sinai Medical Center Miami, FL)

Presenter: Regina Deible

October 29, 2013

Presentation TCT 2013

Cell Therapy for Non-ST Elevation MI: A Phase 1 Study

Presenter: Marc Penn

October 29, 2013

Presentation TCT 2013

The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity

Presenter: David Maron

October 29, 2013

Presentation TCT 2013

When, Why, and How to Cardiovert

Presenter: Mintu Turakhia

October 29, 2013

Presentation TCT 2013

How Do I Optimize Stent Implantation?

Presenter: John Hodgson

October 29, 2013

Presentation TCT 2013

TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV...

Presenter: Thierry Lefevre

October 29, 2013

Advertisement

Slides

Prognostic impact of chronic total occlusion in ischemic heart disease - A report from the Swedish Coronary Angiography and Angioplasty Registry

Hybrid Therapy: The Best of Both Worlds (and Considerations for a CTSN-Sponsored Randomized Trial)

Prognostic impact of chronic total occlusion in ischemic heart disease and different age categories - A report from the Swedish Coronary Angiography and Angioplasty Registry

Predicting the Future in Five Years: How Much AS Will Be Treated with TAVR vs AVR?

Case 1: Complex Coronary Artery Disease (Mount Sinai Medical Center Miami, FL)

Cell Therapy for Non-ST Elevation MI: A Phase 1 Study

The Decision to Revascularize Must Be Made on the Background of Improving Medical Therapies and Life Style Modification, with Greater Longevity

When, Why, and How to Cardiovert

How Do I Optimize Stent Implantation?

TCT-69. Safety and clinical performance of the drug eluting Orsiro stent in patients with single de novo coronary artery lesions – II (BIOFLOW-II) -A quantitative analysis by IV...

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content